Showing results (271-280 of 299) with videos related to
Sort By:
Pageof 30
Journal of Gastroenterology and Hepatology|June 1, 2022
The diagnostic ability to classify neoplasias occurring in inflammatory bowel disease by artificial intelligence and endoscopists: A pilot studyShumpei Yamamoto, Hideaki Kinugasa, Kenta Hamada, et al.Endocrine Oncology (Bristol, England)|April 25, 2025
Clinical characteristics and prognosis of histological subtypes of papillary thyroid carcinoma in pediatric patientsJunko Akaishi, Kiminori Sugino, Tetsuo Kondo, et al.Thyroid : Official Journal of the American Thyroid Association|January 21, 2023
Incidence of and Risk Factors for Neonatal Hypothyroidism Among Women with Graves' Disease Treated with Antithyroid Drugs Until DeliveryAi Yoshihara, Jaeduk Yoshimura Noh, Kosuke Inoue, et al.American Journal of Epidemiology|November 24, 2020
Behavioral Problems at Age 11 Years After Prenatal and Postnatal Exposure to Acetaminophen: Parent-Reported and Self-Reported OutcomesKosuke Inoue, Beate Ritz, Andreas Ernst, et al.Journal of the Endocrine Society|December 22, 2021
Delayed Follow-up Visits and Thyrotropin Among Patients With Levothyroxine During the COVID-19 PandemicKosuke Inoue, Jaeduk Yoshimura Noh, Ai Yoshihara, et al.Endocrine Journal|May 6, 2024
Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracilJaeduk Yoshimura Noh, Kosuke Inoue, Nami Suzuki, et al.Clinical and Experimental Nephrology|April 9, 2013
Serum level of soluble (pro)renin receptor is modulated in chronic kidney diseaseKazu Hamada, Yoshinori Taniguchi, Yoshiko Shimamura, et al.Plos One|December 11, 2013
5-Aminolevulinic acid protects against cisplatin-induced nephrotoxicity without compromising the anticancer efficiency of cisplatin in rats in vitro and in vivoYoshio Terada, Keiji Inoue, Tatsuki Matsumoto, et al.Endocrine Journal|September 24, 2023
Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive scoreNatsuko Watanabe, Jaeduk Yoshimura Noh, Ai Kozaki, et al.Plos One|April 28, 2022
Characteristics of aldosterone-producing adenomas in patients without plasma renin activity suppressionHaremaru Kubo, Yuya Tsurutani, Kosuke Inoue, et al.Pageof 30